Here are some of the major companies whose stocks moved on the week’s news ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.

Eli Lilly is getting closer to bringing a weight loss pill to market, but CEO David Ricks notes certain factors need to be considered to prevent prices from ballooning.

We recently published a list of the 10 Best Long Term Stocks to Buy According to Billionaires. In this article, we are going ...

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows ...